CTIS2023-504340-34-01
Active, not recruiting
Phase 1
Drug-Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI (DEBATE)
Wellbeing Services County Of North Karelia Siun Sote0 sites534 target enrollmentOctober 15, 2023
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Wellbeing Services County Of North Karelia Siun Sote
- Enrollment
- 534
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age \= 18 years, informed written consent, at least one major or two minor bleeding risk criteria of Academic Research Consortium (ARC). Either of the following: Stabile angina or dyspnea and a coronary narrowing causing myocardial ischemia detected in the angiogram. In stable patients prior PCI, the evidence of ischemia is needed acquired either by perfusion imaging or by pressure wire measurement (FFR) during coronary angiography unless the coronary stenosis is \> 90% in diameter. ACS (UAP or NSTEMI): symptoms of heart ischemia\= 20 minutes and \= 0,5mm ST\-depression or transient ST\-elevation or T\-wave inversion at least in two adjacent leads and/or a high sensitivity troponin (hs\-tnt) rise at least one unit above the 99\. percentil or at least 50% rise in hs\-tnt between two samples taken 1\-3 hours apart. At least one of the following: \=1 de novo lesions in native coronary arteries or bypass vein grafts. Reference diameter of the vessel is 2\.0\-5\.0mm. Lesion length \= 40mm. Lesion or lesions are suitable for PCI.
Exclusion Criteria
- •Inability to give written consent STEMI. Reference diameter of the vessel is \<2\.0mm or \>5\.0 mm. Bifurcation lesion requiring the stenting of either of the branches after predilatation. (TIMI\<3 or significant recoil \>30% in the main epicardial vessel: LAD, LCX or RCA) after predilatation). Dissection affecting the flow (TIMI\<3\) or significant recoil (\>30% in the main epicardial vessel: LAD, LCX or RCA) after predilatation. In\-stent restenosis. Chronic total occlusion. Life expectancy \< 12 months. Cardiogenic shock at the arrival to the coronary angiography. Uncertainty about neurological recovery e.g. after resuscitation. Need for bypass surgery by heart team decision.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Safety and efficacy of drug-coated balloon angioplasty following high-speed rotational atherectomy in calcified coronary lesionscalcified coronary stenotic lesionsJPRN-UMIN000023017Shiroyama Hospital50
Recruiting
Not Applicable
Drug-Coated Balloon Versus Drug-Eluting Stent for Treatment of De-Novo Coronary Lesions in Patients with High Bleeding RiskDiseases of the circulatory systemKCT0006983Samsung Medical Center1,350
Not yet recruiting
Phase 3
Drug-Coated Balloons versus Drug-Eluting Stents for Treatment of De-Novo Coronary Artery Lesions in Patients with Stable Coronary Artery Disease - the COATED Trial.arteriosclerosiscoronary artery disease10011082NL-OMON51852Vrije Universiteit Medisch Centrum230
Withdrawn
Not Applicable
Drug eluting BALLoon angioplasty to prime bifuRcation lesiOns for stenting: a prOspective randoMized trialNL-OMON33521Sint Antonius Ziekenhuis200
Not yet recruiting
Not Applicable
DRUG COATED BALLOON ANGIOPLASTY IN FAILING ARTERIOVENOUS GRAFTS IN END STAGE RENAL DISEASEKidney DiseasePACTR202011880135496niversity of the Witwatersrand and PI Prof Deirdre Kruger120